Avian Influenza Vaccine Market Size to Cross USD 735.22 Million by 2025 at a CAGR of 7.25%, Predicts Market Research future (MRFR)

By Globe Newswire8 days ago

Pune, India, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Avian Influenza Vaccine Market Overview:

Market Research Future (MRFR) studied the Global Avian Influenza Vaccine Market 2020 across the analysis period till 2025. By 2025, the Avian Influenza Vaccine Market can register 7.25% CAGR. On the conclusion of forecast tenure, the Avian Influenza Vaccine Market can value at USD 735.22 Mn. The rise in government initiatives to promote awareness about avian influenza and increase in funding for research by private organizations to formulate effective avian influenza vaccines can underpin the expansion of the market in the analysis period. Strategic agreements among private and government authorities to improve healthcare solutions and mutual effort in digitalization of medical assistance facilities can add to the market upsurge.

The growing prevalence of diseases across developing regions can contribute to the high mortality of poultry. At the same time, the rise in demand for poultry for consumption is creating need for research to develop effective vaccines for prevention of the disease. Gene editing technology can make chickens resistant against avian flu. In addition, certain law allows the hen bird flu to be culled. EggXYt, a biotech company that provide detection of the sex of chick embryos, is observed to develop tool that can end the costly practice of culling. Amidst pandemic, Punjab is observed to issues advisory for the surveillance of wetlands, and poultry farms as bird flu outbreaks. These are some illustrations supporting modern developments to meet the market demand.

The avian influenza virus is likely to cause infection in humans by inhalation through nose, or can enter through eyes, nose, and mouth. The avian influenza virus can be transmitted by mucous, saliva, and feces. The avian influenza vaccines market can largely be influenced by the environment of developing regions that are conducive for viral contagiousness, following financial status. The COVID 19 impact assessment for the avian influenza vaccine market offers extensive data on the dynamics of the market due to recurrent outbreak of bird flu amidst the pandemic.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/8769

Prominent Players:

Some Major Companies in the worldwide Avian Influenza Vaccine Market are:

  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva (US)
  • Guangdong Wenshi Dahuanong Biotechnology Co. Ltd (China)
  • Avimex Animal Health (Mexico),
  • FATRO S.P.A. (Italy)
  • Zoetis (US)
  • CAVAC (South Korea)
  • PT Japfa Comfeed Indonesia Tbk (Indonesia)
  • Full story available on Benzinga.com

Continue read on benzinga.com